Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
ConclusionsData from an integrated analysis of studies in TD and an integrated analysis of studies of chorea in HD showed that deutetrabenazine has a favorable safety profile and is well tolerated across indications.Trial RegistrationClinicalTrials.gov identifiers, NCT02291861, NCT02195700, NCT01795859, NCT02198794, NCT01897896.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Anxiety | Brain | Depression | Dyskinesia | Headache | Huntington's Disease | Migraine | Neurology | Study